Scopoderm is a therapeutic option to control drooling just for severely disabled patients. So it’s not suitable for everyone for this purpose. It may also cause adverse effects.
A clinical study of the efficacy of Scopoderm in managing drooling showed the following results:
69% reduction in drooling by the end of week 1
80% reduction in drooling at the end of week 2 [popover id=ref1]